Following its highly successful initial ETF, Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (OTC: HMLSF), which boasts assets in excess of C$700 million, Canadian fund manager Horizons ETF has created a second ETF that will begin trading on February 14th, the Horizons Emerging Marijuana Growers Index ETF. Unlike the first one, this ETF will not trade on the Toronto Stock Exchange, instead listing on the NEO with the symbol HMJR.
HMJR will give investors direct exposure to a growing group of Canadian and global marijuana cultivation and distribution companies. Marijuana producers are generally well-positioned to take part in the anticipated global expansion of the marijuana sector.
Steve Hawkins, President and Co-CEO of Horizons ETFs
The company has published a two-page product sheet and has filed a prospectus describing the details of the fund, which has a goal of replicating the performance of the Solactive Emerging Growers Index. The index include companies focused on cultivation, production and/or distribution of cannabis with market capitalization between $50 million and $500 million. The fund may include up to 20% issuers outside of North America, and its index includes 21% Australian companies, some of which aren’t accessible easily to investors outside of the country.
The index includes 26 companies:
- Canadian LPs ABcann Global, Beleave, Benchmark Botanics, Canada House Wellness Group, Delta 9 Cannabis, Emblem Corp, Harvest One Cannabis, Hiku Brands, Hydropothecary, Indiva, Maricann Group, TerrAscend and WeedMD
- ACMPR applicants Liberty Leaf Holdings, PUF Ventures, and Valens Groworks
- U.S. focused companies Marapharm Ventures, MPX Bioecuetical and Nutritional High
- Hemp processor Hempco Food & Fiber
- Uruguay operator ICC Labs
- Australian companies AusCann Group, Cann Group, The Hydroponics Company, Creso Pharma and MGC Pharma
